Abdominal CT Radiation Risk

Patients with inflammatory bowel disease (IBD) and other gastrointestinal disorders can be exposed to high levels of radiation—mostly from abdominal computed tomography (CT) scans—reports the March issue of Clinical Gastroenterology and Hepatology. Access to high-quality facilities and technologic advances have increased the use of CT imaging of the GI tract.

Read more

Can Imaging Identify the Most Dangerous Pancreatic Cystic Neoplasms?

Endoscopic ultrasound can be used to identify cystic neoplasms of the pancreas that are most likely to become malignant, according to the February issue of Clinical Gastroenterology and Hepatology. Mucus-producing cystic neoplasms of the pancreas, including intraductal papillary mucinous neoplasm (IPMN) and mucinous cystic neoplasm (MCN), that have mural nodules

Read more

Does Celiac Disease Increase the Risk of GI Cancer?

People with celiac disease do not have an increased risk of developing gastrointestinal (GI) cancers, according to a large population-based study from Peter Elfström et al. in the January issue of Clinical Gastroenterology and Hepatology. Celiac disease has been associated with GI cancers in small studies, but there have been

Read more

Dangerous Diabetes Drugs?

The drugs sitagliptin and exenatide, used to treat patients with type 2 diabetes, increase risk for pancreatitis and cancer, according to a study from Michael Elashoff and colleagues published in the July issue of Gastroenterology. The authors examined the United States (US) Food and Drug Administration’s database of reported adverse

Read more

Surviving Childhood Cancer Increases GI Risks

Individuals who received therapy for cancer during childhood have an increased risk of developing GI complications later in life, according to Robert Goldsby et al. in the May issue of Gastroenterology. About 80% of children who receive cancer therapy survive more than 5 years; therapies can be especially toxic to

Read more

For Pancreatic Cysts—(Change in) Size Matters

The speed of cyst growth predicts whether branch duct intraductal papillary mucinous neoplasms (Br-IPMNs) will become malignant, according to a study by Mee Joo Kang et al. in the January issue of Clinical Gastroenterology and Hepatology. IPMN is a premalignant pancreatic lesion that progresses from adenoma to carcinoma; cysts are

Read more